Multigenic control of skin tumor susceptibility in SENCARA/Pt mice

B A Mock1, D T Lowry, I Rehman

  • 1Laboratory of Genetics, DBS, NCI, National Institutes of Health, Bethesda, MD 20892-4255, USA.

Carcinogenesis
|July 17, 1998
PubMed

Insights

Skin tumor development in mice is controlled by multiple genes. A specific genetic locus on chromosome 5 (Skts4) influences susceptibility and resistance to papilloma formation, indicating a multigenic control of skin tumors.

Area of Science:

  • Genetics
  • Oncology
  • Dermatology

Background:

  • Skin tumors, such as papillomas, can be induced in mice using chemical carcinogens like DMBA and TPA.
  • The development of chemically induced skin tumors is a complex process influenced by genetic factors.

Purpose of the Study:

  • To identify genetic loci associated with susceptibility and resistance to chemically induced skin tumors in mice.
  • To investigate the genetic basis of multigenic control in skin tumor formation.

Main Methods:

  • A genome scan was performed on 81 N2 mice derived from a cross between BALB/cAnPt and SENCARA/Pt strains.
  • Eighty-nine microsatellite markers were used to analyze associations between genetic loci and tumor phenotypes (resistant vs. susceptible).
  • Loss of heterozygosity analysis was conducted on microdissected papillomas.

Main Results:

  • A significant genetic locus on chromosome 5 (Skts4) was identified, controlling both the resistance of BALB/cAnPt mice and the susceptibility of SENCARA/Pt mice to papilloma formation.
  • Elevated linkage scores were observed for markers on chromosomes 9 and 11, suggesting potential involvement in tumor development.
  • No evidence of loss of heterozygosity was found in the analyzed microsatellite markers on chromosomes 5, 9, and 11 in the examined papillomas.

Conclusions:

  • Skin tumor formation is under multigenic control, with a major locus (Skts4) on chromosome 5 playing a key role.
  • Further investigation is warranted to confirm the role of genetic regions on chromosomes 9 and 11 in papilloma development.
  • The identified genetic locus provides a target for understanding the mechanisms underlying skin tumor susceptibility and resistance.